GlyNAC vs Urolithin A: Which Is Better for Longevity?

Photo by Vitaly Gariev on Unsplash

By The Longevity Dose Editorial Team · Evidence-reviewed · Last updated August 2026

GlyNAC vs urolithin A is a comparison that comes up constantly among people who’ve moved past basic supplements and want to target the biology of aging more precisely. Both have real human trial data behind them, which already puts them ahead of most longevity supplements. Both work on mitochondrial health, which a 2024 review in Sports Medicine identified as one of the most critical targets for slowing the physical decline that comes with age. But they work differently, their evidence bases differ meaningfully, and they’re not the same price. This post breaks it down so you can make an informed call.

GlyNAC: The Amino Acid Combo With Surprising Trial Results

What It Is and How It Works

GlyNAC is a combination of two amino acid precursors: glycine and N-acetylcysteine (NAC). Together, they raise glutathione, the body’s master antioxidant, which declines significantly with age. Low glutathione levels are linked to mitochondrial dysfunction, increased oxidative stress, and impaired insulin sensitivity. The idea is that you can’t efficiently absorb enough cysteine from food alone to meaningfully restore glutathione, so NAC fills that gap while glycine provides the other half of the molecule.

Glycine also has independent benefits worth noting. It’s a precursor to collagen, supports sleep quality, and may reduce inflammation through pathways separate from glutathione. If you’ve read our post on collagen vs. glycine for longevity, you’ll recognize why glycine alone gets attention in aging research. But the GlyNAC combination appears to be more powerful than either component alone.

What the Human Evidence Actually Shows

The most cited GlyNAC research comes from Dr. Rajagopal Sekhar at Baylor College of Medicine. His pilot RCT, published in The Journal of Nutrition, Health and Aging (2021), enrolled 8 older adults aged 71-80 and supplemented them with GlyNAC for 24 weeks. Results included significant improvements in glutathione levels, mitochondrial function, oxidative stress markers, inflammation, endothelial function, body composition, and cognitive scores. That’s a striking list from a single intervention. However, eight participants is a very small sample. These are hypothesis-generating results, not definitive proof.

A follow-up RCT by the same group, published in Clinical and Translational Medicine (2022), tested GlyNAC against placebo in 24 older adults for 16 weeks. Participants taking GlyNAC showed improvements in muscle strength, exercise capacity, gait speed, and several metabolic markers compared to placebo. Evidence strength: small randomized controlled trial in humans, which is meaningful but needs replication in larger cohorts. You can read more about the dosing details we’ve covered in our dedicated GlyNAC supplement dosage guide.

Practical Use and Dosing

The dose used in Sekhar’s published trials was weight-based — you can find the exact protocol in the primary papers in The Journal of Nutrition, Health and Aging (2021) and Clinical and Translational Medicine (2022), which are worth reading directly before deciding on a dose. What that works out to in grams for your own bodyweight is worth calculating from the published protocol rather than relying on a blog to hand you a number, since the dose is the part that matters most to get right. Most commercial GlyNAC products use doses noticeably lower than those in the published trials, so it is worth comparing the label to the trial protocol before assuming equivalence. Whether lower doses produce the same benefits isn’t confirmed. Both ingredients are available cheaply in powder form, and you can source them separately if you want flexibility. Total cost for a full-dose protocol can be as low as $30-50 per month, which is genuinely accessible.

Downsides and Honest Caveats

High-dose NAC can cause nausea in some people, especially on an empty stomach. There’s also theoretical concern that very high antioxidant supplementation could blunt some of the adaptive stress response from exercise. The studies don’t show this happening in practice, but it’s worth knowing if you’re stacking GlyNAC with intense training. And critically: all existing trials are small, short, and from one primary research group. Independent replication at scale is still needed.

Urolithin A: The Mitophagy Activator From Pomegranates

What It Is and How It Works

Urolithin A is a compound your gut bacteria produce when they metabolize ellagitannins, found in pomegranates, walnuts, and some berries. The catch: your ability to produce urolithin A depends entirely on which gut bacteria you carry, and a meaningful share of people produce little or none regardless of how many pomegranates they eat. That’s why supplementing with it directly is increasingly common. Its primary mechanism is activating mitophagy, the cellular process of clearing out damaged mitochondria so healthy ones can replace them. Think of it as garbage collection for your cells’ power plants. Our full comparison with another autophagy-related compound is covered in the spermidine vs urolithin A post if you want a deeper dive.

Urolithin A also activates muscle protein synthesis pathways and appears to reduce inflammation. In animal models, it extended lifespan in C. elegans roundworms and improved muscle function in older mice. But animal results don’t automatically transfer to humans, and the honest framing matters here.

What the Human Evidence Actually Shows

The strongest human evidence comes from a phase II RCT published in JAMA Network Open (2022) by researchers at the Amazentis group and academic collaborators. The trial enrolled 88 older adults aged 65-90 and tested 500 mg and 1000 mg of urolithin A versus placebo for four months. Key findings: urolithin A improved muscle endurance (measured by hand grip fatigue and six-minute walk test) at the 1000 mg dose, and upregulated mitochondrial gene expression in muscle biopsies. Plasma markers of inflammation also improved. No serious adverse events were reported.

This is a proper double-blind RCT in older humans with a reasonable sample size. That’s meaningful. But four months isn’t long enough to know whether mitophagy improvements translate into slower aging or reduced disease risk over years. The mitochondrial gene expression findings are biologically coherent with the proposed mechanism, which strengthens confidence. Evidence rating: promising phase II human RCT; long-term efficacy data still pending.

Practical Use and Dosing

The trial dose that showed benefit was 1000 mg/day. The proprietary form used in most supplements is Mitopure, developed by Amazentis. It typically costs $60-100 per month at full dose, making it significantly more expensive than GlyNAC. You can also increase dietary ellagitannins from pomegranate and walnuts, but there’s no reliable way to know if you’re a urolithin A producer without testing. For most people, supplementing directly removes that uncertainty.

Downsides and Honest Caveats

Urolithin A’s main limitation is cost. At $80-100 per month for a properly dosed supplement, it’s one of the pricier options in the longevity space. Most of the published research also comes from or involves the company that holds the Mitopure patent, which isn’t disqualifying, but it’s worth knowing. Independent academic replication using generic urolithin A forms would strengthen confidence considerably. Also, the mechanism of mitophagy activation is well-established in cells and animals, but the human clinical endpoints tied to longevity (reduced disease incidence, mortality) haven’t been demonstrated yet.

Head-to-Head Comparison: GlyNAC vs Urolithin A

The Verdict: Which One Should You Actually Take?

If you can only pick one, start with GlyNAC. Here’s the reasoning: the breadth of outcomes tested in Sekhar’s trials is wider. Improvements in strength, cognition, metabolism, oxidative stress, and inflammation from a single, cheap intervention is a compelling signal. The evidence is limited by sample size, but the effect sizes were large enough to be meaningful even with small groups. And at $30-50 per month, the cost-to-potential-benefit ratio is hard to beat among evidence-based supplements.

Urolithin A makes sense as an add-on, not a replacement. Its mechanism (mitophagy activation) doesn’t overlap heavily with GlyNAC’s (glutathione restoration), which means stacking them is biologically coherent rather than redundant. If you’re specifically focused on muscle endurance and mitochondrial quality, urolithin A has the stronger and larger trial backing for those specific endpoints. People over 65 dealing with early sarcopenia warning signs may find the combination worthwhile.

Neither supplement replaces exercise. The 2024 Sports Medicine review on mitochondria and aging is clear that exercise remains the primary intervention for preserving physical function. Supplements in this space work best when layered on top of consistent training, not instead of it.

For women navigating muscle loss after menopause, both interventions are relevant. Our guide to muscle loss after menopause explains why mitochondrial decline accelerates in that period specifically, which is exactly the biology GlyNAC and urolithin A are targeting.

GlyNAC is the better first purchase. Urolithin A is the better second one, if budget allows. Neither is a magic bullet, and anyone claiming otherwise is overselling the current evidence.

Affiliate Disclosure: The Longevity Dose may earn a small commission if you purchase through the links below, at no additional cost to you. We only recommend products we genuinely believe in. Learn more.

Frequently Asked Questions

Can you take GlyNAC and urolithin A together?

Yes, and the combination is biologically coherent. GlyNAC raises glutathione and reduces oxidative stress, while urolithin A clears damaged mitochondria through mitophagy. These mechanisms don’t overlap significantly, so stacking them targets mitochondrial health from two different angles. No safety concerns have been identified with combining them, though no trials have tested the combination directly.

How long does it take for GlyNAC to work?

In Dr. Sekhar’s RCTs, meaningful improvements in oxidative stress markers appeared within the first few weeks, while muscle strength and cognitive improvements were measured at the 16-24 week mark. The trial endpoints in Sekhar’s published RCTs were measured at 16-24 weeks, which gives you a reasonable anchor for how long to commit before drawing conclusions about whether it is working for you. Starting at a lower NAC dose and building up can help minimize any initial nausea.

Is urolithin A worth the cost?

At $60-100 per month, urolithin A is expensive relative to most supplements. The phase II RCT published in JAMA Network Open (2022) does support its use for muscle endurance in older adults, particularly at the 1000 mg dose. Whether that translates into meaningful longevity benefit long-term isn’t yet established. If budget is a constraint, GlyNAC is a more accessible starting point with comparably compelling (if smaller) trial data.

What foods contain urolithin A?

Urolithin A isn’t found directly in food. Your gut bacteria produce it when you eat ellagitannin-rich foods like pomegranates, walnuts, and certain berries. The catch is that converting ellagitannins into urolithin A requires specific gut bacteria that not everyone carries, so dietary intake alone is an unreliable route for a large portion of people. Supplementing with urolithin A directly bypasses this variability entirely.

Does GlyNAC help with brain aging?

In Dr. Sekhar’s pilot trial, older adults taking GlyNAC for 24 weeks showed improvements in several cognitive measures compared to baseline. These included memory and processing speed markers. However, that trial enrolled only 8 participants, so the cognitive findings should be considered preliminary. GlyNAC’s mechanism of reducing oxidative stress and neuroinflammation is biologically plausible for brain health, but larger trials are needed to confirm this.

Is urolithin A safe for long-term use?

Available human trial data, including the 2022 JAMA Network Open RCT running for four months, found urolithin A to be safe with no serious adverse events at doses up to 1000 mg/day. Longer-term safety data beyond six months in humans is limited as of 2026. The compound also has a long history of human exposure through food-derived production in the gut, which provides some baseline confidence in its safety profile.